CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $35,033 (100.0% shares, 0.0% debt)

Holdings (10)

— STRONGBRIDGE BIOPHARMA PLC 73.1%

Value ($000) $25,626 Shares 5,394,994 Est. Cost $2.41 Unrealized —

— AGILE THERAPEUTICS INC 14.9%

Value ($000) $5,204 Shares 1,623,567 Est. Cost $6.32 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 4.3%

Value ($000) $1,491 Shares 8,945 Est. Cost $132.86 Unrealized +25.9%

— GARRISON CAP INC 1.8%

Value ($000) $646 Shares 66,073 Est. Cost $9.61 Unrealized —

— CM FIN INC 1.5%

Value ($000) $540 Shares 53,204 Est. Cost $9.47 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 1.1%

Value ($000) $395 Shares 13,263 Est. Cost $25.50 Unrealized +13.1%

ADNT ADIENT PLC 1.0%

Value ($000) $344 Shares 4,737 Est. Cost $50.50 Unrealized +27.0%

— TEAM HEALTH HOLDINGS INC 1.0%

Value ($000) $336 Shares 7,713 Est. Cost $43.46 Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 0.8%

Value ($000) $289 Shares 1,992 Est. Cost $130.25 Unrealized 0.0%

— CIDARA THERAPEUTICS INC 0.5%

Value ($000) $162 Shares 20,802 Est. Cost $14.41 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	STRONGBRIDGE BIOPHARMA PLC	5,394,994	$25,626	73.1%	$2.41	—	SHS USD	G85347105
—	AGILE THERAPEUTICS INC	1,623,567	$5,204	14.9%	$6.32	—	COM	00847L100
BRK/B	BERKSHIRE HATHAWAY INC DEL	8,945	$1,491	4.3%	$132.86	+25.9%	CL B NEW	084670702
—	GARRISON CAP INC	66,073	$646	1.8%	$9.61	—	COM	366554103
—	CM FIN INC	53,204	$540	1.5%	$9.47	—	COM	12574Q103
ACRS	ACLARIS THERAPEUTICS INC	13,263	$395	1.1%	$25.50	+13.1%	COM	00461U105
ADNT	ADIENT PLC	4,737	$344	1.0%	$50.50	+27.0%	ORD SHS	G0084W101
—	TEAM HEALTH HOLDINGS INC	7,713	$336	1.0%	$43.46	—	COM	87817A107
JAZZ	JAZZ PHARMACEUTICALS PLC	1,992	$289	0.8%	$130.25	0.0%	SHS USD	G50871105
—	CIDARA THERAPEUTICS INC	20,802	$162	0.5%	$14.41	—	COM	171757107